| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/17/2011 | US20110067121 Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications |
| 03/17/2011 | US20110066130 Abuse Potential Reduction in Abusable Substance Dosage Form |
| 03/17/2011 | US20110065125 Controlled platelet activation to monitor therapy of adp antagonists |
| 03/17/2011 | US20110064676 Diagnostic and therapeutic nanoparticles |
| 03/17/2011 | US20110064675 Elemental iron nanoparticles |
| 03/17/2011 | US20110064674 Luminescent multimodal nanoparticle probe system and method of manufacture thereof |
| 03/17/2011 | US20110064673 New L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them |
| 03/17/2011 | US20110064672 Articles and Compositions for Enhancing Sports Scores |
| 03/17/2011 | US20110064671 Modulation of blood brain barrier permeability |
| 03/17/2011 | US20110064670 Method to identify a patient with an increased likelihood of responding to an anti-cancer agent |
| 03/17/2011 | US20110064668 J-superfamily conotoxin peptides |
| 03/17/2011 | US20110064667 Azide modified proteins |
| 03/17/2011 | US20110064666 Compound |
| 03/17/2011 | US20110064665 Diagnostic and therapeutic nanoparticles |
| 03/17/2011 | US20110064664 Methods and compositions involving chitosan nanoparticles |
| 03/17/2011 | US20110064663 Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use |
| 03/17/2011 | US20110064660 Deuterated alkyl phospholipid compounds, compositions, and methods of use |
| 03/17/2011 | US20110064659 Glutamine biomarkers for depression |
| 03/17/2011 | US20110064658 RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors |
| 03/17/2011 | US20110064655 Biomarkers for depression |
| 03/17/2011 | US20110064654 Prostate cancer diagnosis and treatment |
| 03/17/2011 | US20110064653 Class I Anti-CEA Antibodies and Uses Thereof |
| 03/17/2011 | US20110064652 Nanoparticles for targeted delivery of active agents to the lung |
| 03/17/2011 | US20110064651 Recombinant nucleotide sequence, cell or vector containing the same and method for using cell containing the same to encode anti-polyethylene glycol monoclonal antibodies |
| 03/17/2011 | US20110064650 Microorganisms for preventing and treating neoplasms accompanying cellular therapy |
| 03/16/2011 | EP2295998A1 Magnetic resonance imaging system and magnet comprising a polarizer |
| 03/16/2011 | EP2295085A1 Method and device for producing a gas mixture |
| 03/16/2011 | EP1412388B1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 03/16/2011 | CN101985443A Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 03/16/2011 | CN101985037A Applications of receptor for activated C-kinase 1 as target against tumor drug-resistance |
| 03/16/2011 | CN101407815B Use of glycine-N-methyltransferase (GNMT) in preparing medicine for preventing and treating disease derived from flavacin |
| 03/15/2011 | US7906626 using bispecific antibodies comprising an antibody having binding specificity which confers the ability to cross the blood-brain barrier, and a second antibody conferring the ability to bind to beta -amyloid epitopes, used for the treatment of Alzheimer's disease or Down's syndrome |
| 03/15/2011 | US7906290 Antibody recognizing misfolded proteins that can be assigned specifically to one of the diseases |
| 03/15/2011 | US7906123 Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof |
| 03/15/2011 | US7906121 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 03/15/2011 | US7906104 Methods for detecting pancreatic beta-islet cells and diseases thereof |
| 03/10/2011 | WO2011027940A1 Paramagnetic polynuclear metal complex having high self-relaxation rate, preparation method thereof, and contrast medium containing same |
| 03/10/2011 | WO2011027738A1 Molecular probe for imaging islets of langerhans, and use therefore |
| 03/10/2011 | WO2011026808A1 Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles |
| 03/10/2011 | WO2011026572A1 Dispersant stabilization of inorganic non-metallic particles |
| 03/10/2011 | WO2010130365A3 Use of high-doses of monomeric contrast medium containing iodine in x-ray diagnostics, in particular in interventional x-ray diagnostics and in radiation therapy assisted by contrast media containing iodine |
| 03/10/2011 | WO2010125088A3 Nanoparticle contrast agents for diagnostic imaging |
| 03/10/2011 | WO2010063403A3 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation |
| 03/10/2011 | US20110059066 PAKs as Modifiers of the CHK Pathway and Methods of Use |
| 03/10/2011 | US20110059024 Liposome composition, and diagnostic contrast agent, therapeutic enhancer, and pharmaceutical composition using the same |
| 03/10/2011 | US20110059023 Narrowband imaging using near-infrared absorbing nanoparticles |
| 03/10/2011 | US20110059022 Two photon tracer, method for the preparation thereof and the use thereof in screening anticancer agents |
| 03/10/2011 | US20110059021 Process for preparing variant of erysipelothrix rhusiopathiae surface protective antigen in e. coli |
| 03/10/2011 | US20110059020 Liposome composition, and diagnostic contrast agent, therapeutic enhancer, and pharmaceutical composition using the same |
| 03/10/2011 | US20110059019 Novel aryl piperazine derivatives useful as modulators of dopamine and serotonin receptors |
| 03/10/2011 | US20110059018 Covalently binding imaging probes |
| 03/10/2011 | US20110059017 Polymer coated sers nanotag |
| 03/10/2011 | US20110059016 Optical assay system with a multi-probe imaging array |
| 03/10/2011 | US20110059015 Vaccine |
| 03/10/2011 | US20110059013 Anti-robo4 antibodies and uses therefor |
| 03/10/2011 | CA2772708A1 Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles |
| 03/10/2011 | CA2771254A1 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13) |
| 03/09/2011 | EP2293065A2 Methods and compositions for diagnosing hepatocellular carcinoma |
| 03/09/2011 | EP2292275A2 Protecting therapeutic compositions from host-mediated inactivation |
| 03/09/2011 | EP2291642A1 Light imaging apparatus, system and method |
| 03/09/2011 | EP2291199A2 Capsulating system binding to nucleolin |
| 03/09/2011 | EP1420830B1 Ocular diagnosis of alzheimer's disease |
| 03/09/2011 | CN101983724A Rapid high-throughput screening model for antiviral drugs |
| 03/08/2011 | US7902421 Animal model for schizophrenia |
| 03/08/2011 | US7902144 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 03/08/2011 | US7901898 Tuberculosis diagnostic test |
| 03/08/2011 | US7901770 Embolic compositions |
| 03/08/2011 | US7901689 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 03/08/2011 | US7901681 Trypanosome derived apoptotic factors (TAF) |
| 03/03/2011 | WO2011026103A2 Systems and methods for producing hyperpolarized materials and mixtures thereof |
| 03/03/2011 | WO2011025078A1 Use of trypan blue for dyeing bonghan corpuscles or bonghan ducts, and dyeing method of bonghan corpuscles or bonghan ducts |
| 03/03/2011 | WO2011024467A1 Orally administrable tablet for intestinal lavage |
| 03/03/2011 | WO2011024156A1 Isotopically labeled neurochemical agents and uses thereof for diagnosing conditions and disorders |
| 03/03/2011 | WO2011003902A3 Multimodal visible polymer embolization material |
| 03/03/2011 | WO2010126319A3 Lipopeptide with specific affinity to the fc region of an antibody, and antigen-recognizing lipid nanoparticle comprising same |
| 03/03/2011 | WO2010028216A8 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 03/03/2011 | US20110054301 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent |
| 03/03/2011 | US20110054237 Methods and Systems for Magnetic Focusing of Therapeutic, Diagnostic or Prophylactic Agents to Deep Targets |
| 03/03/2011 | US20110052708 Methods and formulations for the delivery of pharmacologically active agents |
| 03/03/2011 | US20110052505 Post-biopsy cavity treatment implants and methods |
| 03/03/2011 | US20110052504 Contrast agents |
| 03/03/2011 | US20110052503 Biodegradable contrast agents |
| 03/03/2011 | US20110052502 MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof |
| 03/03/2011 | US20110052501 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
| 03/03/2011 | US20110052500 TAJ in Neuronal Function |
| 03/03/2011 | US20110052499 Baboon homolog of human cd147 |
| 03/03/2011 | US20110052498 Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related Disorders |
| 03/03/2011 | US20110052497 Minimally Invasive Systems and Methods for In Vivo Testing of Materials |
| 03/03/2011 | US20110052496 Hollow nanoparticles and uses thereof |
| 03/03/2011 | US20110052495 Use of fullerenes in photoacoustic imaging |
| 03/03/2011 | US20110052494 H-antigen binding polypeptides and methods of use |
| 03/03/2011 | US20110052493 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1 |
| 03/03/2011 | US20110052490 Endoscopic mucosal resectioning using purified inverse thermosensitive polymers |
| 03/03/2011 | US20110052489 Anti-CD19 Antibodies |
| 03/03/2011 | US20110050228 agent for transporting nuclear spin order and for magnetic resonance imaging |
| 03/03/2011 | DE102007004283B4 Magnetresonanz-Kontrastmittel mit eisenbindendem Protein Magnetic resonance contrast agent with eisenbindendem protein |
| 03/03/2011 | CA2772489A1 Isotopically labeled neurochemical agents and uses thereof for diagnosing conditions and disorders |
| 03/03/2011 | CA2772190A1 Systems and methods for producing hyperpolarized materials and mixtures thereof |
| 03/02/2011 | EP2290611A1 Medical image diagnostic apparatus and method using a liver function anagiographic image, and computer readable recording medium on which is recorded a program therefor |
| 03/02/2011 | EP2290083A1 Conserved neisserial antigens |